Cogent Biosciences (COGT) Asset Utilization Ratio (2018 - 2020)
Cogent Biosciences' (COGT) quarterly Asset Utilization Ratio came in at 0.04 in Q4 2020, down 90.39% year-on-year from 0.42 in Q1 2020, and down 85.13% on a QoQ basis from 0.27 in Q3 2020.
Cogent Biosciences (COGT) Asset Utilization Ratio (2018 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has 3 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2020.
- On a quarterly basis, Asset Utilization Ratio fell 90.39% year-over-year to 0.04 in Q4 2020; TTM through Dec 2020 was 0.04, a 90.39% decrease from a year earlier, with the FY2020 full-year figure at 0.05, down 84.23% from the prior year.
- Asset Utilization Ratio for Q4 2020 stood at 0.04, down from 0.27 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for COGT reached as high as 0.68 in Q2 2020 and fell as low as 0.04 in Q4 2020.
- Historically, Asset Utilization Ratio has averaged 0.25 across 3 years, with a median of 0.17 in 2019.
- On a YoY basis, Asset Utilization Ratio climbed as much as 374.14% in 2020 and fell as far as 90.39% in 2020.
- Year by year, Asset Utilization Ratio stood at 0.11 in 2018, then soared by 289.25% to 0.42 in 2019, then plunged by 90.39% to 0.04 in 2020.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.04 in Q4 2020, 0.27 in Q3 2020, and 0.68 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cogent Biosciences | 6.87 Bn | 6.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.04 |
| Sep 30, 2020 | 0.27 |
| Jun 30, 2020 | 0.68 |
| Mar 31, 2020 | 0.60 |
| Dec 31, 2019 | 0.42 |
| Sep 30, 2019 | 0.17 |
| Jun 30, 2019 | 0.16 |
| Mar 31, 2019 | 0.13 |
| Dec 31, 2018 | 0.11 |
| Sep 30, 2018 | 0.08 |
| Jun 30, 2018 | 0.11 |
| Mar 31, 2018 | 0.19 |